EMA provides tracking tool for relocation to Amsterdam

The European Medicines Agency (EMA) has released a new tracking tool which shows the main milestones and work stream deliverables for the Agency’s move from London to Amsterdam. The EMA states that they are committed to giving stakeholders and the public full visibility of the relocation project, due to its important role in safeguarding public and animal health in the European Union (EU). The tracking tool will allow anyone who is interested to follow the progress made on the relocation.

A joint governance structure has been agreed between the EMA and the Netherlands with five work streams relating to the temporary and permanent premises, staff relocation, financial and legal aspects, and external communication.

The tracking tool provides an overview of the key milestones agreed for each of the work streams, except external communications which are an ad-hoc activity dependent on the progress made with the other work streams. The tool also gives further details on the deliverables for each work stream, highlighting whether the EMA is on track to meet them. As the timelines are interactive, users may find out more information by hovering their mouse over each pinned deliverable.

“The Dutch authorities have committed to building completely new, tailor-made premises for EMA in the Zuidas business district which are expected to be available from 15 November 2019. For an interim period until the new building is complete, EMA will occupy temporary premises in the Sloterdijk area of Amsterdam.”

The tracking tool is a living document which will updated every month, and milestones may be added as the project progresses.

To view the tracking tool for the relocation of the EMA to Amsterdam, please click here.